1. Two regulators, two different questions
The Health Sciences Authority (HSA) is relevant where the material could be presented as a therapeutic product. Genuinely research-use-only material with no therapeutic claim sits outside the HSA's product registration regime, provided the RUO basis is applied consistently.
The National Environment Agency (NEA) administers the hazardous substances control scheme. If the peptide or its formulation is classified as a hazardous substance under the Globally Harmonised System, the importing entity needs a hazardous substances licence or a permit before import. Your safety officer or chemical inventory manager will know whether your institution holds one that covers this class of material.
2. Customs, classification and duty
- Importer of record — requires a UEN or business registration with Singapore Customs, and the ability to lodge a import declaration
- Classification — research peptides generally fall under heading 2937 in the Singapore Customs Tariff, which follows the ASEAN Harmonised System
- Duty — Singapore applies an MFN rate on most lines, with preferential rates available to India-origin material under the ASEAN–India FTA. The rules of origin are the gate. Material must originate in India or qualify under substantial transformation in the exporting country, and a Certificate of Origin must be valid. A China-manufactured peptide shipped from a Singapore supplier does not qualify — that is worth confirming before you sign for anything
- GST — 9% on the CIF value plus duty, reclaimable by a GST-registered importer
Our HS code and import duty reference explains the origin rules in detail, including why the "Preferential" column printed in the Indian Customs Tariff is the ASEAN rate and why it prints 10% for Chapter 29 — worse than the 7.5% MFN rate.
3. Singapore as an APAC hub
Singapore is frequently used as a regional consolidation point for Australia, New Zealand and parts of Southeast Asia. If that is your pattern, three things matter:
- Origin preservation on re-export. The Certificate of Origin and the supporting evidence must travel with the goods, and the re-export must be documented so the preferential claim survives. Losing the origin evidence at the hub is a common and expensive mistake
- Storage conditions in transit. Singapore is a hot, humid port. For lyophilised material this is not a chemistry problem, but it is a documentation problem — your insurer and your quality team will want to see the storage and handling record
- Re-export licensing. Certain controlled goods require a re-export permit. We will state the nature of the material accurately on the paperwork so your broker can confirm whether one is needed
4. What we issue for Singapore destinations
- Commercial invoice with CAS number and description
- Batch Certificate of Analysis with chromatogram and mass spectrometry confirmation
- MSDS
- Certificate of Origin
- Packing list and airway bill
- Declaration of conformity to your specification
5. Institutional requirements
Research importers in Singapore generally need the importing entity's hazardous substances licence or permit status confirmed, an institutional chemical inventory entry, and a safety assessment for the receiving site. Where a NEA hazardous substances licence is required, it must be in place before the import is declared.
Related: export documentation · HS code and import duty · incoterms
B2B trade only — request a quote
All peptides are research-grade, for in-vitro use only, and supplied against a valid drug licence. Tell us your sequence, quantity and destination and the trade desk will respond within one business day.